|
AU2006200494A1
|
|
A process for identifying the active site in a biological target
|
|
GB0323235D0
|
|
Topically administrable pharmaceutical compositions
|
|
GB0322645D0
|
|
Use of antisecretory factor peptides
|
|
GB0322644D0
|
|
Antisecretory factor peptides
|
|
ZA200306481B
|
|
Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors.
|
|
GB0303364D0
|
|
Heteroaromatic compounds
|
|
GB0303366D0
|
|
Pharmaceutically active phenyl-pyrrole derivatives
|
|
GB0219895D0
|
|
Pharmaceutically active compounds
|
|
GB0219897D0
|
|
Pharmaceutically active compounds
|
|
GB0219893D0
|
|
Pharmaceutically active compounds
|
|
BR0207706A
|
|
diaminoquinazoline esters for use as dihydrofolate reductase inhibitors
|
|
GB0119167D0
|
|
Aminoguanidines
|
|
GB0119174D0
|
|
Aminoguanidines
|
|
GB0119172D0
|
|
Phenyl pyrrole derivatives
|
|
GB0119169D0
|
|
Novel pyridyl-piperazines
|
|
GB0118399D0
|
|
Novel amides
|
|
GB0118402D0
|
|
Novel tertiary amides
|
|
GB0108630D0
|
|
Novel piperidines acting on the melanocortin receptors
|
|
GB0108628D0
|
|
Novel purines acting on the melanocortin receptors
|
|
GB0108627D0
|
|
Novel pyrazines acting on the melanocortin receptors
|
